Cartesian Therapeutics, Inc. — Form D

Cartesian Therapeutics, Inc. of GAITHERSBURG, MD, a company, filed a Form D exempt-offering notice with the SEC on 2020-01-02. The offering totals $70.0M, of which $70.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (88)

Showing 25 of 88 people.

NameRoleLocation
Scott Dunseth MyersDirectorWatertown, MA
Amir Dunseth NashatDirectorWatertown, MA
Aymeric Dunseth SallinDirectorWatertown, MA
Timothy Dunseth SpringerDirectorWatertown, MA
Patrick Dunseth ZennerDirectorWatertown, MA
Bradford DahmsExecutive OfficerWatertown, MA
Lloyd JohnstonExecutive OfficerWatertown, MA
Alison Kei SchecterExecutive OfficerWatertown, MA
Stephen Kei SmolinskiExecutive OfficerWatertown, MA
CARL GORDONDirectorSAN DIEGO, CA
Werner CautreelsDirectorWaltham, MA
Werner CautreelsExecutive OfficerWaltham, MA
Timothy A SpringerDirectorWatertown, MA
Chris A JewellExecutive OfficerGaithersburg, MD
Michael C SingerDirectorGaithersburg, MD
Kemal C MalikDirectorGaithersburg, MD
Carsten BrunnDirectorGaithersburg, MD
Carsten BrunnExecutive OfficerGaithersburg, MD
Metin A KurtogluExecutive OfficerGaithersburg, MD
Timothy C BarabeDirectorGaithersburg, MD
Nishan C de SilvaDirectorGaithersburg, MD
Patrick A ZennerDirectorGaithersburg, MD
Emily A EnglishExecutive OfficerGaithersburg, MD
Carrie S CoxDirectorGaithersburg, MD
Blaine DavisExecutive OfficerGaithersburg, MD

Other filings by this issuer (15)

FiledFormOfferingSold
2024-07-17D$130.0M$130.0M
2023-12-04D/A$60.3M$60.3M
2023-12-01D$60.3M$60.3M
2020-08-18D$25.0M$25.0M
2019-09-04D$5.8M$5.8M
2017-07-11D$50.0M$50.0M
2016-12-14D$5.0M$5.0M
2015-09-10D$40.6M$37.4M
2015-04-23D$7.5M$5.9M
2014-08-28D$4.5M$4.5M
2014-07-15D$6.0M$6.0M
2014-04-09D$10.0M$5.3M
2011-11-17D$26.0M$3.5M
2011-11-17D$22.0M$22.0M
2010-04-06D$15.0M$15.0M

More